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Abstract
Purpose To examine the feasibility, reliability, and
validity of the newly developed EQ-5D-Y.
Methods The EQ-5D-Y was administered in population
samples of children and adolescents in Germany, Italy,
South Africa, Spain, and Sweden. Percentages of missing
values and reported problems were calculated. Test–retest
reliability was determined. Spearman’s rank correlation
coefﬁcients with other generic measures of HRQOL were
calculated. Known groups’ validity was examined by
comparing groups with a priori expected differences in
HRQOL.
Results Between 91 and 100% of the respondents pro-
vided valid scorings. Sweden had the lowest proportion of
reported problems (1–24.9% across EQ-5D-Y dimensions),
with the highest proportions in South Africa (2.8–47.3%)
and Italy (4.3–39.0%). Percentages of agreement in test–
retest reliability ranged between 69.8 and 99.7% in the EQ-
5D-Y dimensions; Kappa coefﬁcients were up to 0.67.
Correlation coefﬁcients with other measures of self-rated
health indicated convergent validity (up to r =- 0.56).
Differences between groups classiﬁed according to
The EQ-5D-Y is a copyrighted instrument. All requests for EQ-5D-Y
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DOI 10.1007/s11136-010-9649-xpresence of chronic conditions, self-rated overall health
and psychological problems provided preliminary evidence
of known groups’ validity.
Conclusions Results provide preliminary evidence of the
instrument’s feasibility, reliability and validity. Further
study is required in clinical samples and for possible future
applications in economic analyses.
Keywords Child health  Adolescent health  HRQOL 
Measurement  EQ-5D
Abbreviations
HRQOL Health-related quality of life
VAS Visual analogue scale
EQ-5D-Y EQ-5D youth version
Introduction
The assessment of young people’s health-related quality of
life (HRQOL) is considered to be of increasing importance
in public health research and the evaluation of medical and
psychosocial treatment [1, 2]. A large number of measures
of HRQOL have been developed speciﬁcally for children
and adolescents (here deﬁned as persons aged 8–11 and
12–18, respectively) taking the special requirements in
these age-groups into account [1, 3–6]. However, one
disadvantage of those instruments is their lack of corre-
spondence to adult HRQOL instruments. This shortcoming
makes it difﬁcult to track changes in HRQOL across the
life course in, for example, cohort studies investigating
severe or progressive chronic childhood conditions that last
into adulthood. It is therefore desirable to have a modiﬁed
version of an adult instrument at hand that is also suitable
for younger age-groups and can be used in the transition
from childhood and adolescence into adulthood.
The generic EQ-5D is a brief and easy to administer
instrument that provides scores for different health
dimensions as well as an index value which can be used to
assess health status and is useful in health economic
analyses. Since the EQ-5D has been utilized internationally
in many different settings, such as clinical trials and pop-
ulation surveys [7], the instrument was considered a suit-
able candidate for development of a modiﬁed version that
could be used in children and adolescents. Within the
framework of an international task force on behalf of the
EuroQol Group including 13 experts in quality of life
research from seven countries (Germany, Italy, South
Africa, Spain, Sweden, the Netherlands, United Kingdom),
a version for use in respondents from 8 years onwards—the
EQ-5D-Y—was developed based on the standard adult EQ-
5D. All experts additionally had speciﬁc expertise in child
psychology, paediatrics, health economics, statistics, sport
sciences, or rehabilitation sciences. The methodology of
the questionnaire development process of the EQ-5D-Y as
well as background information regarding the modiﬁca-
tions and their consequences are described elsewhere [8].
In summary, the development process included the revision
of the content and wording of EQ-5D to ensure relevance
and clarity for young respondents. After translation of the
resulting modiﬁed version, cognitive interviews were
conducted in Germany, Italy, Spain and Sweden to test the
instrument’s comprehensibility in children and adolescents.
Results indicated the adapted EQ-5D-Y was satisfactorily
understood by young respondents in different countries and
that it might be a useful tool to measure HRQOL in chil-
dren and adolescents in an age-appropriate manner.
In order to investigate the feasibility, reliability, and
validity of the EQ-5D-Y in a multinational, multilinguistic
context, a series of national validation studies were
undertaken which were coordinated and methodologically
harmonized to ensure the comparability of the ﬁndings.
The results from the validation studies performed in ﬁve
countries (Germany, Italy, South Africa, Spain, Sweden)
are presented in the current paper.
Since the EQ-5D is widely used for economic evaluation
purposes, many questions arise with respect to the EQ-5D-
Y regarding the possible development of preference
weights in the future. Even though this paper concentrates
on the new EQ-5D-Y as a stand-alone outcome measure as
it is used in many settings (such as population health sur-
veys, routine health system use, and use in clinical set-
tings), we will address some of these important questions in
an outlook at the end.
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123Methods
Study design and sample description
In general, study methodologies used in the different
countries were comparable; however, some variations in
individual countries were permitted so that local teams
could study speciﬁc research questions. National represen-
tativeness was not a priority in this study as representative
population samples are not a requirement of validation
studies. The main characteristics of the national studies are
presented in Table 1. A minimum number of n = 200 EQ-
5D-Y respondents per country was required according to
previous power calculations [8]. In order to include
respondents aged 8 and older from the general population,
schools were used for recruitment in all countries, except
Sweden (household sample). Only mainstream schools, i.e.
not special-needs schools were included in the sample.
Pupils who were present on the day of questionnaire
administration constituted the study sample. They com-
pleted the questionnaires in the classroom on their own and
were provided with short written instructions. In Italy, an
investigator was present to provide assistance. No restric-
tions were made regarding the mother tongue of the pupils,
although the questionnaires were presented in the language
of instruction in the schools. In Italy, only native Italian
speakers were included. In Sweden, families received the
questionnaire, a letter to the parents explaining the study,
and a similar letter for the child by post. A reminder was
sent after2 weeks, which includedthe questionnaire and the
two letters. The letters emphasized that the child should
complete the questionnaire on his or her own.
Test–retest procedures were conducted in Italy and in
Spain in order to investigate reliability of EQ-5D-Y, where
a third of the study sample received the questionnaire again
7–10 days after the ﬁrst examination.
In all countries, informed consent from parents or
guardians was a precondition for children and adolescents
to be able to participate in the study. Depending on national
regulations, permission to collect data was obtained from
the data protection commissioner in charge (Germany,
Italy, and Spain) or the appropriate ethics committee
(Sweden: Karolinska Institutet Number 2006/1534-31/2;
South Africa: Medical Research Ethics Committee of the
University of Cape Town and South African Department of
Education).
Instruments and variables
To examine convergent and known group validity of the
EQ-5D-Y, a core set of internationally standardized
instruments and variables was administered alongside the
EQ-5D-Y and questions regarding basic socio-demo-
graphic information (age, gender, level of education,
migration status) in all national studies. Since these
instruments needed to be available in a variety of languages
and to have been shown to be valid for use in cross-cultural
comparison studies, many instruments from international
studies [9, 10] were employed here. The core set included
measures of HRQOL and subjective health to analyse
convergent validity as well as indicators of mental and
somatic health problems, e.g. a screener for emotional and
behavioural problems.
EQ-5D-Y
The EQ-5D-Y was developed from the EQ-5D by adapting
the original questionnaire to the requirements of measuring
HRQOL in children and adolescents from 8 years onwards
[8]. As in the adult version, it consists of a descriptive
system that comprises ﬁve items referring to mobility
(‘walking about’), self-care (‘looking after myself’), usual
activities (‘doing usual activities’), pain and discomfort
(‘having pain or discomfort’), and anxiety and depression
(‘feeling worried, sad or unhappy’). Each item has three
levels of problems reported (no problems, some problems,
Table 1 Characteristics of the different national samples
Germany Italy South Africa Spain Sweden
Data collection School (pupils) School (pupils) School (pupils) School (pupils) Postal survey
(from general population)
Study design Cross-sectional Cross-sectional & retest Cross-sectional Cross-sectional & retest Cross-sectional
Mode of recruitment Random sample Convenience sample Convenience sample Convenience sample Random sample
Method of application Paper–pencil Paper–pencil Paper–pencil Paper–pencil Paper–pencil
N 756 415 258 973 407
Male 385 199 130 494 208
Female 371 216 128 479 199
Age-range 10–18 8–15 13–19 8–18 8–16
Mean age (SD) 13.8 (1.9) 11.8 (2.2) 15.5 (1.3) 13.0 (2.7) 13.2 (2.7)
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123a lot of problems). The EQ-5D-Y also includes an easily
understandable modiﬁcation of the vertical, graduated
Visual Analogue Scale (VAS) of EQ-5D, where the
respondent rates his or her overall health status on a scale
from 0 and 100 with 0 representing the worst and 100 the
best health state he or she can imagine. All items refer to
the health state ‘today’.
KIDSCREEN-27
The generic KIDSCREEN-27 was administered as a cross-
cultural measure to assess HRQOL in children and ado-
lescents aged 8–18. Its ﬁve Rasch-scaled dimensions pro-
vide detailed proﬁle information on physical well-being,
psychological well-being, autonomy & parents, peers &
social support, and school environment within the last
week. The instrument has been shown to have good psy-
chometric properties with internal consistencies of the
subscales ranging between 0.80 and 0.84 [10]. In addition,
the KIDSCREEN-10 Index score provides an overall
measure of global HRQOL using 10 of the KIDSCREEN-
27 items [11].
PedsQL
The PedsQL
TM Quality of Life generic core Scales were
administered in Italy. The instrument consists of 23 items
that can be grouped in 4 multidimensional scales (physical
functioning, emotional functioning, social functioning,
school functioning) and 3 summary scales [12]. The
PedsQL refers to the last month and is suitable for self-
completion by respondents aged 8–18.
Self-rated health
The general health item asks the respondent how he or she
would describe his or her health in general and was used in
all countries as a measure of perceived health status.
Response options were ‘excellent’, ‘very good’, ‘good’,
‘fair’ and ‘poor’. This question has been used in large
international health surveys in children and adolescents and
has been shown to be a valid measure of subjective health
[13].
Cantril-ladder
The adapted version of Cantril’s ‘life-satisfaction-ladder’
[14] used in WHO surveys in children and adolescents was
included to measure general subjective life satisfaction.
Respondents were presented with the picture of a ladder
with steps ranging from 0 to 10 and asked to indicate where
on the ladder they ‘feel they are standing at the moment’
with the top of the ladder (10) representing the best
possible life and the bottom (0) representing the worst
possible life.
Strength and Difﬁculties Questionnaire (SDQ)
To test for known group validity differences between
responders with and without emotional and behavioural
problems, the SDQ [15, 16] was administered in Germany
and Spain. The SDQ is a short behavioural screening
instrument that asks the respondent for 20 symptoms of
mental health problems within the last 6 months (regarding
behaviour, emotions, hyperactivity-inattention and peer
problems). A total difﬁculties score can be calculated and
is recoded into three categories (normal, borderline,
abnormal mental health problems). For the present study,
the borderline and abnormal categories were collapsed.
Chronic condition
Responders were asked ‘Do you have a long-term chronic
condition or disability which had been diagnosed by a
health professional?’ and ‘Do you take medicine for your
long-term illness, disability or medical condition?’ to
establish whether respondents had a longstanding illness,
disability or medical condition. The question about medi-
cation should indicate the severity of the condition reported
[17].
Statistical analysis
The feasibility and acceptability of EQ-5D-Y was investi-
gated by calculating the percentage of missing values and
inappropriate responses on the descriptive system and
VAS. A missing value was deﬁned as a respondent com-
pletely leaving out an item or the VAS. Responses on the
VAS that did not indicate unambiguously one score (e.g.
by drawing a circle that included more than one score)
were also deﬁned as missing values. Responses that did not
follow the instruction of drawing a line from the box to the
chosen VAS score but which provided an unambiguously
interpretable score (e.g. when a pupil used the VAS like a
thermometer, drawing a line from the bottom to one score)
were deﬁned as inappropriate responses. Frequencies of
reported problems were calculated for all samples from the
ﬁve participating countries.
In order to investigate reliability, the percentage of
agreement and kappa coefﬁcients [17] was calculated to
estimate concordance between test and retest responses (‘no
problem’versus ‘any problems’)ineach proﬁle domain. For
theVAS,theintraclasscorrelationcoefﬁcient(ICC)[18]was
computed. Kappa values were interpreted according to
Landis and Koch’s guidelines [19] with kappa\0.2 indi-
cating poor agreement, 0.21–0.40 indicating fair agreement,
890 Qual Life Res (2010) 19:887–897
1230.41–0.60 moderate agreement, 0.61–0.80 substantial
agreement, and kappa[0.81 indicating almost perfect
agreement. An ICC[0.7 is generally considered as
acceptable for test–retest reliability. When applicable, a
P-value\0.05 (two-tailed test) was considered as statisti-
cally signiﬁcant.
Convergent validity was investigated by determining the
correlations between EQ-5D-Y dimensions and VAS and
previously validated measures of child HRQOL using
Spearman’s rank and Pearson’s correlation coefﬁcients,
respectively [20]. In line with the guidelines provided by
Cohen et al. [21], coefﬁcients from 0.1 to 0.29 were
deemed to be low, 0.3 to 0.49 moderate and correlations of
0.5 or above as high. It was hypothesized that the mobility
and the pain and discomfort dimension of the EQ-5D-Y
would show a moderate correlation with dimensions of
physical well-being and other QoL measures. Even though
the level of an individual’s physical activity, energy and
ﬁtness as assessed by the KIDSCREEN-27 physical well-
being dimension is not directly related to the experience of
pain and discomfort as assessed by the relevant EQ-5D-Y
dimension, a moderate relationship could be expected as
both aspects refer to physical health and well-being. Fur-
ther, it was hypothesized that the ‘feeling worried, sad or
unhappy dimension’ would show a moderate to high cor-
relation with dimensions of psychological well-being and
that a similar level of correlation would be seen between
the VAS and overall scores of QoL measures as well as
with general health items and life satisfaction.
The known groups’ validity of the EQ-5D-Y was exam-
ined by comparing the results on the descriptive system
between groups which were a priori expected to show dif-
ferences in HRQOL. Groups analysed were: (a) those
reporting a chronic condition and taking medication for that
condition versus those reporting no chronic condition,
(b) those with excellent, very good or good self-reported
health versus those with fair or poor self-reported health on
theGeneralHealthItem,and(c)thosewhohadmentalhealth
problems based on their SDQ scores versus those who did
not. Comparisons were performed using v
2-tests, and the
categories of ‘some’ and ‘a lot of problems’ were collapsed
to one category (‘any problems’).
Results
Feasibility
Complete data was obtained for 91–100% of respondents
from the general population samples depending on the
country and the part of the EQ-5D-Y (descriptive system
vs. VAS). Missing or inappropriate responses on the EQ-
5D-Y dimensions ranged from 0% in Spain and Italy to 2%
in South Africa. On the VAS, the level of missing or
inappropriate responses ranged from 0% in Italy to 9% in
Germany.
Distribution of EQ-5D scores: frequencies of reported
problems
Table 2 shows the proportion of respondents reporting
problems on EQ-5D-Y dimensions by country. In all coun-
tries,thehighestproportionsofproblems(i.e.‘some’/‘alot’)
were reported on the ‘having pain and discomfort’ and
‘feeling worried, sad or unhappy’ dimensions. In all coun-
tries,problemswerereportedleastfrequentlyonthe‘looking
aftermyself’dimension.Highceilingeffectswereseeninall
dimensions. In general, the proportion of respondents
reporting anyproblemwashighestinItalyandSouthAfrica.
Swedish respondents reported fewer problems compared to
the other countries.
Reliability
Table 3 shows the results on test–retest reliability. In the
descriptive system, a test–retest agreement was observed in
69.8–93.8% of Italian youths and in 86.2–99.7% of Spanish
respondents. This agreement is generally conﬁrmed by the
kappa coefﬁcients. However, the high ceiling effects in the
descriptive system of EQ-5D-Y caused some apparent non-
conﬁrmation of the results. In Italy, no kappa coefﬁcient
could be computed for the self-care domain since all
children reported no problems in the retest. Similarly, the
kappa coefﬁcients in the mobility dimension are of limited
value since nearly all retest responses were in the ‘no
problems’ category. The intraclass correlation coefﬁcients
(ICCs) for the VAS were 0.82 in Italy and 0.83 in Spain.
Convergent validity
Regarding convergent validity, Table 4 shows the corre-
lations between the EQ-5D-Y and selected KIDSCREEN-
27 dimensions and the KIDSCREEN-10 score by country.
Similar patterns of associations between the scores on both
instruments in the different countries could be observed. As
hypothesized, the two dimensions dealing with psycho-
logical well-being in the EQ-5D-Y and the KIDSCREEN-
27 showed moderate to high correlations (r =- 0.41 to
-0.52), suggesting convergent validity. In Italy, the
Spearman rank coefﬁcient between PedsQL Emotional
functioning and ‘feeling worried, sad or unhappy’ was q =
-0.47 (data not shown in Table 4). Conversely, the mobility
dimension of the EQ-5D-Y barely correlated with the psy-
chological well-being dimension of the KIDSCREEN-27
(Table 4) or the PedsQL Emotional functioning Scale
(q =- 0.10). Generic questions on well-being and life
Qual Life Res (2010) 19:887–897 891
123satisfaction such as the self-rated general health item, the
KIDSCREEN-10QoLIndexandtheLifeSatisfactionLadder
showed moderate to high correlations with the EQ-5D-Y
VAS (correlation coefﬁcients from 0.33 to 0.56), which also
suggestsadequateconvergentvalidity.Associationsbetween
the KIDSCREEN-27 dimension of physical well-being and
the EQ-5D-Y mobility and pain or discomfort dimension
werelowanddidnotreachtheexpectedcorrelationthreshold
of q = 0.3. The same was true for the correlations between
the PedsQL Physical functioning scale and the EQ-5D-Y
mobilityandpaindimensions.The‘lookingaftermyself’and
‘usualactivities’dimensionsdidnotcorrelatewithanyofthe
selected established HRQOL dimensions or with the general
health item or life satisfaction ladder.
Known groups’ validity
As presented in Table 5, respondents reporting a chronic
condition and taking medication for that condition reported
signiﬁcantly more problems on the EQ-5D-Y dimensions of
Table 2 Percentages of reported problems in the EQ-5D-Y
Germany (n = 756) Italy (n = 415) South Africa (n = 258) Spain (n = 973) Sweden (n = 407)
% n % n % n % n % n
Mobility (walking about)
No 91.9 695 93.5 388 85.3 220 95.3 927 96.3 392
Some 7.5 57 6.3 26 12.0 31 4.6 45 2.7 11
A lot of 0.1 1 0.2 1 0.4 1 0.1 1 0.0 0
Missing values 0.4 3 0 0 2.3 6 0 0 1.0 4
Looking after myself
No 97.9 740 95.7 397 95.0 245 98.6 959 98.0 399
Some 1.6 12 4.1 17 2.7 7 1.1 11 1.0 4
A lot of 0.3 2 0.2 1 0.4 1 0.3 3 0.0 0
Missing values 0.3 2 0 0 1.9 5 0 0 1.0 4
Doing usual activities
No 93.3 705 84.3 350 82.6 213 93.7 912 95.8 390
Some 6.2 47 14.9 62 14.7 38 5.7 55 2.7 11
A lot of 0.3 2 0.7 3 0.8 2 0.6 6 0.3 1
Missing values 0.3 2 0 0 1.9 5 0 0 1.2 5
Having pain or discomfort
No 62.0 469 61.0 253 51.6 133 80.0 778 74.0 301
Some 36.0 272 38.3 159 45.7 118 19.0 185 23.6 96
A lot of 1.3 10 0.7 3 0.8 2 1.0 10 0.7 3
Missing values 0.7 5 0 0 1.9 5 0 0 1.7 7
Feeling worried, sad or unhappy
Not 59.8 452 61.0 253 60.1 155 76.9 748 80.3 327
A bit 35.8 271 34.7 144 34.1 88 22.0 214 18.2 74
Very 3.8 29 4.3 18 3.9 10 1.1 11 0.5 2
Missing values 0.5 4 0 0 1.9 5 0 0 1.0 4
Table 3 Test–retest reliability
in Italy and Spain (retest after
7–10 days)
* Signiﬁcant at P B 0.01
a The responses in the retest are
identical
Italy Spain
Kappa coefﬁcient Agreement (%) Kappa coefﬁcient Agreement (%)
Mobility (walking about) 0.222 91.5 -0.003* 99.4
Looking after myself 0.000
a 93.8 0.665* 99.7
Doing usual activities 0.352* 82.9 0.557* 97.5
Having pain or discomfort 0.350* 69.8 0.435* 86.2
Feeling worried, sad or unhappy 0.549* 78.3 0.468* 87.4
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123mobility (South Africa, Spain, Sweden), ‘looking after
myself’ (Sweden), ‘doing usual activities’ (Germany, South
Africa), ‘having pain or discomfort’ (Germany, South
Africa) and ‘feeling worried, sad or unhappy’ (Germany,
South Africa, Sweden) than those who declared no chronic
condition for which they were taking medication.
Respondents with ‘fair’ or ‘poor’ self-reported health
displayed signiﬁcantly more problems (P\0.05) on the
‘mobility’ (Germany, South Africa), ‘usual activities’
(Italy, South Africa, Spain, Sweden), ‘pain and discomfort’
(Germany, Spain, Sweden) and ‘anxiety and depression’
(Germany, South Africa, Spain, Sweden) dimensions than
respondents with ‘excellent’, ‘very good’ or ‘good’ self-
reported health (data not shown).
In Germany and Spain, a comparison between respon-
dents with and without mental health problems was con-
ducted (data not shown). Those with borderline and
abnormal SDQ scores reported signiﬁcantly (P\0.05)
more problems on four EQ-5D-Y dimensions (mobility,
usual activities, pain/discomfort and anxiety/depression),
though the largest differences were seen on the ‘feeling
worried, sad or unhappy’ dimension (61.9% reporting
Table 4 Convergent validity:
Spearman rank Correlation
between EQ-5D-Y and
KIDSCREEN, general health
and life satisfaction scores
(signiﬁcant correlations are
given in bold)
a Missing values were excluded
casewise
b Pearson correlation
coefﬁcient
c In Italy (n = 415), Spearman
rank correlations of the General
Health Item with the EQ-5D-Y
descriptive system were for
mobility q = 0.15, ‘looking
after myself’ q = 0.04, ‘doing
usual activities’ q = 0.18,
‘having pain and discomfort’
q = 0.17, ‘feeling worried, sad
and unhappy’ q = 0.20;
Pearson correlation coefﬁcient
with the VAS was r =-0.52
Germany
(n = 756
a)
South Africa
(n = 258
a)
Spain
(n = 973
a)
Sweden
(n = 407
a)
KIDSCREEN-10-HRQOL-index
Mobility (walking about) 20.14 20.27 0.04 20.17
Looking after myself 0.03 0.08 0.01 20.13
Doing usual activities 20.13 20.32 20.10 20.19
Having pain or discomfort 20.28 20.39 20.15 20.30
Feeling worried, sad or unhappy 20.45 20.45 20.14 20.46
VAS
b 0.33 0.54 0.43 0.48
KIDSCREEN-27 physical well-being
Mobility (walking about) 20.10 20.25 20.08 20.15
Looking after myself 0.00 0.03 20.05 20.08
Doing usual activities 20.09 20.21 20.09 20.17
Having pain or discomfort 20.27 20.26 20.18 20.22
Feeling worried, sad or unhappy 20.27 20.29 20.23 20.34
VAS
b 0.33 0.55 0.46 0.47
KIDSCREEN-27 psychological well-being
Mobility (walking about) 20.10 20.21 20.10 20.10
Looking after myself 0.04 0.06 20.04 20.08
Doing usual activities 20.09 20.17 20.14 20.18
Having pain or discomfort 20.28 20.34 20.23 20.27
Feeling worried, sad or unhappy 20.46 20.52 20.41 20.49
VAS
b 0.33 0.48 0.21 0.48
Self-rated general health item
c
Mobility (walking about) 0.13 0.02 20.01 0.15
Looking after myself 20.04 20.09 0.01 0.06
Doing usual activities 0.08 0.27 0.14 0.14
Having pain or discomfort 0.36 0.26 0.21 0.25
Feeling worried, sad or unhappy 0.26 0.25 0.20 0.42
VAS
b 20.46 20.56 20.50 20.51
Life satisfaction ladder
Mobility (walking about) 20.07 20.14 20.12 20.10
Looking after myself 0.01 20.01 0.01 20.01
Doing usual activities 20.05 20.17 20.10 20.10
Having pain or discomfort 20.20 20.15 20.18 20.19
Feeling worried, sad or unhappy 20.32 20.26 20.31 20.37
VAS
b 0.36 0.51 0.54 0.45
Qual Life Res (2010) 19:887–897 893
123problems versus 33.4% for those with and without mental
health problems, respectively, in Germany and 43.5 vs.
19.8%, respectively, in Spain).
Discussion
This study aimed to examine the feasibility, reliability and
validity of the newly developed EQ-5D-Y in four European
countries and South Africa.
The results clearly show that the EQ-5D-Y is easy to ﬁll
in, has few missing values and is highly feasible for chil-
dren as a HRQOL measure. The very low proportions of
missing values in Italy and Sweden may be due to the fact
that an investigator was at hand to help if necessary (Italy),
or because some children might have received assistance at
home (Sweden). On the whole, however, the overall small
proportion of missing or inappropriate responses conﬁrmed
the feasibility of the EQ-5D-Y. Furthermore, the fact that
there are only small differences regarding non-responses
between the countries suggests the instrument might be
viable in a cross-cultural setting. The most frequent prob-
lems were observed in ﬁlling out the VAS, suggesting that
there is potential for further reﬁnement of its presentation
and instruction.
In general, only a low prevalence of severe problems was
reported in the different dimensions of the EQ-5D-Y, which
is typical for general population samples. The highest pro-
portion of problems was reported on the ‘having pain or
discomfort’ and ‘feeling worried, sad or unhappy’ dimen-
sions. For the other EQ-5D-Y dimensions of mobility,
‘looking after myself’ and ‘doing usual activities’, only
relative small proportions of respondents reported prob-
lems. The very high ceiling effects of up to 99% (especially
in the ‘looking after myself dimension) are connected to
several methodical limitations of the new instrument. The
ﬁndings indicate that the ability of EQ-5D-Y to detect
moderate impairments of HRQOL is limited and that con-
sequently the instrument might not be very capable of dis-
criminating between respondents in the general population.
Table 5 Comparison of reported problems on EQ-5D-Y in those with and without self-reported chronic conditions
n Germany Italy South Africa Spain Sweden
Chronic condition Chronic condition Chronic condition Chronic condition Chronic condition
No Yes No Yes No Yes No Yes No Yes
642 95 382 33 188 42 818 155 378 18
Mobility
b,c,d (walking about)
No 92.7 90.4 93.7 90.9 89.4 80.5 95.7 92.9 97.6 88.9
Some 7.3 8.5 6.0 9.1 10.1 19.5 4.3 6.5 2.4 11.1
A lot of 0.0 1.1 0.3 0 0.5 0 0 0.6 0.0 0.0
Looking after myself
d
No 98.1 98.9 95.5 97.0 96.3 100 98.9 96.8 99.2 94.4
Some 1.7 0.0 4.2 3.0 3.2 0 0.9 2.6 0.8 5.6
A lot of 0.2 1.1 0.3 0 0.5 0 0.2 0.6 0.0 0.0
Doing usual activities
a,b
No 93.8 91.6 84.6 81.8 87.8 66.7 94.4 90.3 97.1 94.4
Some 5.9 8.4 14.6 18.2 12.2 31.0 5.0 9.0 2.9 0.0
A lot of 0.3 0.0 0.8 0 0 2.3 0.6 0.7 0.0 5.6
Having pain or discomfort
a,b
No 66.0 41.5 61.5 54.4 58.5 30.9 80.0 80.0 75.4 72.2
Some 32.9 55.3 37.7 45.6 41.0 66.7 19.0 18.7 24.1 22.2
A lot of 1.1 3.2 0.8 0 0.5 2.4 1.0 1.3 0.5 5.6
Feeling worried, sad or unhappy
a,b,d
Not 60.8 54.3 62.0 48.5 63.8 42.9 77.8 72.3 82.3 61.1
A bit 35.4 42.5 34.1 42.4 34.0 42.9 21.4 25.2 17.2 38.9
Very 3.8 3.2 3.9 9.1 2.1 14.2 0.9 2.6 0.5 0.0
a Signiﬁcant differences (P\0.05) between the groups (‘no problem’ vs. ‘any problem’) in Germany
b Signiﬁcant differences (P\0.05) between the groups (‘no problem’ vs. ‘any problem’) in South Africa
c Signiﬁcant differences (P\0.05) between the groups (‘no problem’ vs. ‘any problem’) in Spain
d Signiﬁcant differences (P\0.05) between the groups (‘no problem’ vs. ‘any problem’) in Sweden
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problems in determining the instruments psychometric
properties such as convergent validity and reliability. In this
regard, more differentiated response options can be con-
sidered to be helpful to improve the EQ-5D-Y in the future.
A ﬁve level response choice of the EQ-5D is currently in
development (EuroQol group, personal communication).
On the basis of the data presented here, the development of
such a modiﬁed measure can be highly recommended.
The EQ-5D-Y shows fair to moderate levels of test–
retest reliability, with high percentage of youths reporting
the same levels of problems in the proﬁle domains and
satisfactory ICC with respect to the VAS. However, as
noted above—the examination of reliability was limited by
partly high ceiling effects. Reliability should therefore be
further tested in a different context—e.g. clinical sam-
ples—to reduce these ceiling effects.
Regarding convergent validity, we interpreted correla-
tion coefﬁcients according to the guidelines provided by
Cohen et al. [21]. In interpreting validity correlations, it has
to be considered that due to measurement errors, a corre-
lation can never reachthe maximum of 1but only the square
root of the product of the reliabilities of the instruments
involved. Against this background, it can be said that the
EQ-5D-Y demonstrated convergent validity and displayed
distinct patterns of association with child-speciﬁc measures
of HRQOL and other comparable scales. As expected, the
VAS, as an overall measure of global health, showed the
highest correlation with the KIDSCREEN-10 Index of
general HRQOL, the General Health Item, and with the Life
Satisfaction Ladder.The VAS was also associated with both
physical well-being and psychological well-being, sug-
gesting that VAS scores are driven by aspects of both
physical and psychological health.
The EQ-5D-Y dimension ‘feeling worried, sad or
unhappy’ displayed convergent validity in terms of a strong
association with the KIDSCREEN-27 and PedsQL Psy-
chological Well-being dimension, and discriminant validity
[22] in terms of low correlation with other health infor-
mation. The EQ-5D-Y dimensions ‘mobility’ failed to
display convergent validity—at least with KIDSCREEN-
27 Physical Well-being dimension. However, it can be
argued that by looking at the content of the Physical Well-
being dimension of the KIDSCREEN, the latter is more
focussed on physical well-being/energy level and less on
physical functioning than is the case with the EQ-5D
mobility dimension. Additionally, again the reduced vari-
ation in EQ-5D-Y test scores generally limits the possi-
bilities for correlations with other measures. This might be
improved by extending the range of response options, as
mentioned above.
In general, due to the lack of objective data on the health
of participants, the results on known groups’ validity have
to be interpreted carefully. Overall, the response categories
were used in a more differentiated manner by respondents
who reported health problems. Even though a number of
meaningful differences between the ‘known groups’ could
be detected by the EQ-5D-Y, for no health attribute sig-
niﬁcant differences across all ﬁve countries could be
observed (irrespective of the indicator such as presence of
chronic conditions, impaired self-reported or mental
health). In general, the observed ability of the EQ-5D-Y to
discriminate between the compared groups supports the
validity of all its dimensions but ‘looking after myself’.
However, due to the large ceiling effects, only respondents
with severe health problems seem to be identiﬁed reliably
with the instrument. The fact that differences were not seen
may also be partly attributable to the types of conditions
present. For example, some of the children who report a
chronic condition might do so due to an allergy with minor
symptoms and thus cannot be expected to differ that much
in HRQOL from their ‘healthy’ peers. Furthermore, all
children (except for the Swedish household sample) were
obviously healthy enough to attend school and thus cannot
suffer from a very serious condition.
Even though we observed substantial ceiling effects on
most EQ-5D-Y dimensions, these results are consistent
with those observed when using the EQ-5D in population
health surveys [23]. Although ceiling effects with the adult
version have been shown to be higher than those of other
measures such as the SF-12 and HUI3, the EQ-5D was
nevertheless shown to perform as well or better than those
other instruments in terms of discriminant validity [24]. It
should also be noted that the EQ-5D-Y actually reduced the
ceiling effect on some dimensions in comparison with the
EQ-5D [8]. Finally, it should be remembered that these
were general population samples, where higher ceiling
effects would be expected, and that further testing of the
EQ-5D-Y is required in clinical samples, where the ceiling
effect would likely be signiﬁcantly reduced.
This study has several strengths, but also some limita-
tions. All samples included comprised children and ado-
lescents from the general population. Thus, no information
on the performance of EQ-5D-Y in speciﬁc populations is
available. Another limitation is that due to ethical con-
straints, it was not possible to obtain additional clinical
data on respondents’ physical and psychological health
status. Instead, several screening instruments were used.
However, these additional screeners represent self-report
questionnaires as well. Thus, to a certain extent, the asso-
ciation between these additional measures and the EQ-5D-
Y might be attributable to the ‘same source of information
bias.’ The statistical and psychometric analyses reported in
this paper represent a ﬁrst examination of the EQ-5D-Y
psychometric properties. It was beyond the scope of this
paper to examine other issues, such as sensitivity to
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123change, which should be examined in future studies.
Similarly, the content validity, i.e. whether the instrument
encompasses all aspects of HRQOL that are important in
children and adolescents was not examined, though as
stated earlier, the intention was to adapt an adult tool for
use in children primarily to allow for follow-up and com-
parisons over a wide range of ages.
Another important topic that could not be appropriately
addressed within the scope of this paper is the further
possible use of the new instrument in economic evaluation.
Since there are differences between the EQ-5D-Y and the
standard EQ-5D, the existing social value sets may not be
applicable. Furthermore, valuing EQ-5D-Y health states
raises some potentially interesting issues. The normative
argument using social preference weights in economic
evaluation is that it is the preferences of the general public
that are relevant—not those of patients themselves—in
making resource allocation decisions. This would suggest
that preference weights for the EQ-5D-Y should be
established by eliciting values from the general public, in
much the same manner as for the EQ-5D [25]. Time Trade
Off and other improved methods for eliciting preferences
[26] are equally applicable to the valuation for EQ-5D-Y.
However, it is unclear whether, in asking the general public
to value EQ-5D-Y states, they should be informed that the
states they are being asked to consider will be potentially
experienced by children. Whether participants are informed
or not could conceivably make a difference to the values.
Similarly, there may be a systematic difference between
the values the general public assign to such states and the
values young people themselves place on the states, if they
were asked to consider EQ-5D-Y states hypothetical to
them. This relates to a wider debate about whose values are
relevant in economic evaluations and in how far subgroup
preferences (such as young people) are useful in economic
evaluation [27, 28].
The issue of valuation of EQ-5D-Y states and appro-
priate means by which social preferences for those states
should be elicited is currently under consideration and
discussion and the considerable experience of the entire
EuroQoL group is guiding this process. The present paper
can only provide a basis for this further discussion, since
clearly no weights can be developed until the underlying
descriptor domains are found to be reliable and valid.
Conclusion
In summary, this ﬁrst multinational administration of the
newly developed EQ-5D-Y indicates that it is a feasible,
reliable and valid instrument for the measurement of
HRQOL in children and adolescents. However, the EQ-5D-
Y needs further testing in population-based and clinical
studies. Population-based studies could help to establish
norms for improved interpretation of test scores. Applying
the EQ-5D-Y in clinical studies will allow further testing of
feasibility and acceptance as well as test score distribution
and psychometric properties in more speciﬁc populations
and over a wide range of settings. Longitudinal studies are
required to investigate the measure’s responsiveness with
regard to change in clinical status and to monitor the effect
of medical interventions. The assignment of utility values
to the different health proﬁles described by the EQ-5D-Y
descriptive system should also be a priority in the future.
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